DALLAS, TX

BAYLOR RESEARCH INSTITUTE, THE

Grant: $480,981 - National Institutes of Health - Sep. 30, 2009

Are you satisfied with this award? or

No votes have been cast for this award yet

Join the conversation: Post a comment about this award


Award Description: In collaboration with scienteists at the Unversity of Texas MD Anderson Cancer Center, we will test our immunotherapeutic approach to treating HPV related cancers in a non-human primate model. This study fulfills the premises of the Grand Opportunity Grant by developing safe and potent immunotherapeutic vacines againast HIV-related maliganacies.

Project Description: Aim 1: Engineering , expression , purification and in vitro validation of vaccines; Aim 2: Testing Immunogenicity of vaccines in Rhesus macaques; Aim 3 Selection of a vaccine adjuvant in Rhesus macaques

Jobs Summary: (1) .50 FTE PhD research associate will undertake the construction of the DC - targeting expression vectors. (2) .50FTE bachelor's degree level research assistant will work under Co-Investigator to undertake the required FACS and cell biology analyses to study the binding and activation. (3 & 4) .10 FTE for two lead scientists will help preserve their positions as they lead the project to build expression cell lines secreting the vaccinesclones with antigens linked to recombinant anti-DC monoclonal antibodies.. (Total jobs reported: 0)

Project Status: Not Started

This award's data was last updated on Sep. 30, 2009. Help expand these official descriptions using the wiki below.


Funds Recipient

BAYLOR RESEARCH INSTITUTE, THE
DALLAS, TX 75204
See more awards to this recipient

Place of Performance

3434 Live Oak
Dallas, TX 75204
See more awards in this zip code

Funds from this award have been disbursed to sub-grantees. Click here to see a list of sub-grantees.




Wiki Description

No comments have been added for this project.

Edit the Wiki Description (editing policy)


Post a comment